Cypris Therapeutics is a chemistry-focused pharmaceutical start-up.
Cypris Therapeutics has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2024.
Cypris Therapeutics's investors include Ichor Life Sciences.
Cypris Therapeutics is headquartered in Syracuse, United States.
Cypris Therapeutics is a chemistry-focused pharmaceutical start-up.
Cypris Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cypris Therapeutics — Funding & Investors." VCBacked, June 24, 2024, https://www.vcbacked.co/company/cypris-therapeutics. Accessed August 1, 2026.
VCBacked. (2024). Cypris Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/cypris-therapeutics
{{cite web |title=Cypris Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cypris-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated